Coordinatore | SOLAE DENMARK AS
Organization address
address: SYDHAVNSGADE 7 contact info |
Nazionalità Coordinatore | Denmark [DK] |
Sito del progetto | http://www.magpro2life.eu |
Totale costo | 11˙360˙736 € |
EC contributo | 7˙399˙827 € |
Programma | FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies |
Code Call | FP7-NMP-2008-LARGE-2 |
Funding Scheme | CP-IP |
Anno di inizio | 2009 |
Periodo (anno-mese-giorno) | 2009-07-01 - 2013-06-30 |
# | ||||
---|---|---|---|---|
1 |
SOLAE DENMARK AS
Organization address
address: SYDHAVNSGADE 7 contact info |
DK (ARHUS C) | coordinator | 1˙157˙982.50 |
2 |
Karlsruher Institut fuer Technologie
Organization address
address: Kaiserstrasse 12 contact info |
DE (Karlsruhe) | participant | 1˙436˙841.40 |
3 |
THE UNIVERSITY OF BIRMINGHAM
Organization address
address: Edgbaston contact info |
UK (BIRMINGHAM) | participant | 606˙490.80 |
4 |
MERCK KGAA
Organization address
address: Frankfurter Strasse 250 contact info |
DE (DARMSTADT) | participant | 496˙500.94 |
5 |
TECHNISCHE UNIVERSITAET BERGAKADEMIE FREIBERG
Organization address
address: AKADEMIESTRASSE 6 contact info |
DE (FREIBERG) | participant | 493˙175.62 |
6 |
UNIVERSIDAD DE SALAMANCA
Organization address
address: "Patio de Escuelas, 1" contact info |
ES (SALAMANCA) | participant | 460˙028.34 |
7 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Organization address
address: BELFIELD contact info |
IE (DUBLIN) | participant | 458˙536.20 |
8 |
DANMARKS TEKNISKE UNIVERSITET
Organization address
address: Anker Engelundsvej 1, Building 101A contact info |
DK (KONGENS LYNGBY) | participant | 435˙285.47 |
9 |
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
Organization address
address: Raemistrasse 101 contact info |
CH (ZUERICH) | participant | 429˙352.62 |
10 |
ANDRITZ KMPT GmbH
Organization address
address: Industriestrasse 1-3 contact info |
DE (Vierkirchen) | participant | 368˙322.30 |
11 |
FZMB GMBH FORSCHUNGSZENTRUM FUR MEDIZINTECHNIK UND BIOTECHNOLOGIE
Organization address
address: GERANIENWEG 7 contact info |
DE (BAD LANGENSALZA) | participant | 268˙966.97 |
12 |
BUHLER AG
Organization address
address: GUPFENSTRASSE 5 contact info |
CH (UZWIL) | participant | 190˙117.84 |
13 |
ACADEMIA ROMANA - FILIALA TIMISOARA
Organization address
address: Mihai Viteazu 24 contact info |
RO (Timisoara) | participant | 185˙501.40 |
14 |
INSTITUTUL NATIONAL DE CERCETARE DEZVOLTARE PENTRU FIZICA LASERILOR PLASMEI SI RADIATIEI
Organization address
address: Atomistilor 409 contact info |
RO (Magurele / Ilfov) | participant | 174˙083.90 |
15 |
INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE PENTRU TEHNOLOGII IZOTOPICE SI MOLECULARE-INCDTIM CLUJ-NAPOCA
Organization address
address: Donath 65-103 contact info |
RO (CLUJ - NAPOCA) | participant | 152˙670.10 |
16 |
fluIT Biosystems GmbH
Organization address
address: MIKROFORUM RING 1 contact info |
DE (WENDELSHEIM) | participant | 85˙970.65 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Biotechnologically derived substances for large scale feed, food and pharma applications represent one of the most important sources of new products due to their precisely controlled structural and functional properties, potential for economic and responsible production and overall broad benefits to society through biocompatibility and sustainability. The costs of producing biomaterials are in many cases dominated by separation processes, which can constitute 80% of the total cost of production. Using smart magnetic adsorbent particles to selectively separate the target product out of a complex product mixture like the fermentation broth or bio-feed stock can drastically reduce costs. By using magnetic separation and extraction technologies to separate the magnetic carrier particles, novel processing ways emerge. The main objective of the MagPro²Life project is to scale-up innovative nanotechnology based processes defined in the previous NanoBioMag Project, funded by the EU under the FP6 programme (NMP3-CT-2005-013469), to pilot-line-scale and demonstrate those for bio, food and pharma applications. Link to market needs is represented by a preliminary product selection of natural soy based nutraceuticals or pharmaceuticals like Bowman-Birk Inhibitor (BBI), a proteases inhibitor for MS-treatment, and Lunasin which is in discussion to have anti-carcinogenic properties as well as recombinant proteins and nucleic acids (Fragment-Antibody-Binding and Phytase). The Consortium is driven by the potential the magnetic separation technology has for improving the value-chain in industrial production for emerging biotech, food and pharma markets.'
Extracting the valuable proteins in industrial product mixtures for use in pharmaceuticals and foods is a difficult and expensive endeavour. Functionalised magnetic particles and new processing methods are now doing it safely and inexpensively.